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Abstract
[18_TD$DIFF]Objective: Food intake is highly regulated by central homeostatic and hedonic
mechanisms in response to peripheral and environmental cues. Neutral energy
balance stems from proper integration of homeostatic signals with those
“sensing” the rewarding properties of food. Impairments in brain insulin
signaling causes dysregulation of feeding behaviors and, as a consequence,
hyperphagia. Here, we sought to determine how the mammalian target of
rapamycin complex 2 (mTORC2), a complex involved in insulin signaling,
influences high fat feeding.
[19_TD$DIFF]Methods: Rictor is a subunit of mTORC2, and its genetic deletion impairs
mTORC2 activity. We used Cre-LoxP technology to delete Rictorin tyrosine
hydroxylase (TH) expressing neurons (TH Rictor KO). We assessed food intake,
body weight, body composition and DA dependent behaviors.
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[20_TD$DIFF]Results: TH Rictor KO mice display a high-fat diet specific hyperphagia,
yet, when on low-fat diet, their food intake is indistinguishable from controls.
Consistently, TH Rictor KO become obese only while consuming high-fat diet.
This is paralleled by reduced brain DA content, and disruption of DA dependent
behaviors including increased novelty-induced hyperactivity and exaggerated
response to the psycho stimulant amphetamine (AMPH).
[21_TD$DIFF]Conclusions: Our data support a model in which mTORC2 signaling within
catecholaminergic neurons constrains consumption of a high-fat diet, while
disruption causes high-fat diet-specific exaggerated hyperphagia. In parallel,
impaired mTORC2 signaling leads to aberrant striatal DA neurotransmission,
which has been associated with obesity in human and animal models, as well as
with escalating substance abuse. These data suggest that defects localized to the
catecholaminergic pathways are capable of overriding homeostatic circuits,
leading to obesity, metabolic impairment, and aberrant DA-dependent behaviors.
Keywords: Rictor, mTORC2, Obesity, Dopamine, Amphetamine, High fat diet
Abbreviations: mTORC2: mammalian Target Of Rapamycin Complex 2,
LF: Low fat, HF: High fat, AMPH: Amphetamine, DA: Dopamine
1. Introduction
A range of factors contributes to obesity, including nutritional trends, availability
of highly palatable foods, changes to the built environment, economic stresses,
and others [1]. Feeding is a centrally controlled complex biological behavior
fine-tuned by both homeostatic metabolic drive (hunger or satiety) and hedonic
motivational drive (reward and salience). Therefore, identifying the
neurobiological circuits in which deficits lead to the development of both positive
energy balance (i.e. “homeostatic” or “metabolic” obesity) and/or exaggerated
responses to palatable food (i.e. “hedonic” obesity) is essential for defining
mechanisms involved in the central regulation of food intake.
Akt is a key insulin dependent kinase that influences both peripheral endocrine
responses and higher brain functions such as learning and memory, reward, and
salience [2] [3] [4] [5] [6] [7]. Akt is activated by phosphorylation of two key
residues, Thr308 and Ser473. Mammalian target of rapamycin (mTOR) complex
2 (mTORC2) is a multiprotein complex responsible for phosphorylation of Akt
at Ser473 (pAkt-473). Within hypothalamic neurons, mTORC2 activity is
implicated in mechanisms that control homeostatic neuroendocrine responses
[8]. In the catecholaminergic system, mTORC2 function regulates monoamine
turnover, DA neurotransmission, as well as psychostimulant action [9] [10] [11].
These processes are implicated in reward and salience [12]. This concept is also
supported by data demonstrating that impairment in mTORC2 signaling leads to
escalating morphine self-administration [13].
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The mTORC2 complex consists of Rictor, mSIN1, mLST8, and mTOR. Recent
studies show that conditional deletion of Rictor inhypothalamic centers
leads to hyperphagia, impaired peripheral glucose homeostasis, and obesity
[8]. In order to determine whether Rictor function specifically within
catecholaminergic neurons plays a role in feeding behaviors and metabolism,
we crossed Rictor-Flox mice with mice expressing Cre recombinase under
control of the tyrosine hydroxylase (TH) promoter (TH Rictor KO). We
show that disruption of mTORC2 signaling within catecholaminergic circuits
supports exaggerated hyperphagia in response to palatable high-fat diets.
2. Materials and methods
All procedures were performed according to Vanderbilt University Institutional
Animal Care and Use Committee approved procedures.
2.1. Experimental animals: generation and care
Mice were engineered as previously described [9] [10] [14]. Briefly, C57Bl6 mice
with floxedRictor alleles were crossed to TH-Cre transgenic animals to produce
TH-cell specific Rictor knockout [10_TD$DIFF](TH Rictor KO) mice. Control mice (CTR) were
littermates that lacked the floxed Rictor allele. To genotype the animals, DNA from
tail clippings was analyzed by PCR with primers for the floxed, Cre recombinase,
and recombined alleles as previously described [15]. Male mice were studied from
8 to 18 weeks of age. Mice were housed in a temperature (22 °C) and light (12 h
light/dark cycle) controlled room with free access to standard laboratory rodent
chow diet (#5001, Lab Diet; St. Louis, MO) and water except where indicated.
2.2. Food intake and body composition analysis
Mice (male, 8–12 weeks old) were housed individually; diets (Research Diets, Inc.,
NJ, USA: high fat (HF) product number D12492; low fat (LF) product number
D12450) were randomly assigned. Body weight was determined once per week, on
a standard balance. Body composition was measured by nuclear magnetic resonance
(NMR) in a Bruker Body Composition Analyzer (Bruker Optics; Billerica, MA).
Adiposity (% body fat) was calculated as ((fat mass/lean mass)×100). Caloric intake
(kcal) was determined daily for the first seven days of diet administration and
weekly there after. Feed efficiency is the ratio of weight gained (total body weight,
fat and lean), divided by calories consumed (kcal) over the indicated period.
2.3. Tissue harvest. Monoamine and their metabolites tissue
content
Mice (male, 8–12 weeks old) were sacrificed by rapid decapitation under
volatile isoflurane anesthesia, brains were removed and chilled on ice. Dorsal
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striatum was dissected out from two hemispheres to create comparable samples
for both monoamine content and immunoblotting. After dissection, tissue
was frozen on dry ice and stored in −80 °C until use. Monoamine content was
determined at the Vanderbilt University Neurochemistry Core via high
performance liquid chromatography (HPLC) with amperometric detection as
described previously [16].
2.4. Locomotor behavior
Male mice (8–12 weeks old), were housed in temperature and humidity
controlled rooms and kept on a 12-h light/dark cycle. Food and water were
available ad libitum. Experiments were conducted in accordance with the NIH
guidelines for the care and use of animals and were approved by the Vanderbilt
University Institutional Animal Care and Use Committee. Initial handling lasted
5 days, with daily i.p. saline injections. On day 6 mice were tested for open
field locomotor activity. Four-hour long sessions were performed using
automated experimental chambers (27.9 × 27.9 cm; MED-OFA-510; MED
Associates, Georgia, VT) under constant illumination in a sound-attenuated
room. During days 7–12 mice were habituated to the chambers and saline
injections: four-hour sessions with two saline injections daily (at times
−120 min and 0 min). On day 13, mice were injected with saline at time
−120 min and allowed to explore the chambers for two hours to settle to
comparable baseline. At time 0 min, drugs or vehicle (saline) were administered
i.p. (AMPH 2 mg/kg) and locomotion recorded for the next two hours. Analysis
of open field activity, as well as stereotypic counts was performed using
Activity Monitor (MED Associates).
2.5. Statistical analysis
All data are expressed as the mean ± SEM. Mean differences between groups
were determined using Student's t test or one- or two-way ANOVAs followed
by post hoc testing when the main effect or interaction was significant at
p < 0.05. Statistical analyses were conducted using Graph Pad Prism. The
number of animals and specific statistical analyses used in each experiment are
indicated in the and/or text.
3. Results
3.1. Rictor deletion within catecholaminergic circuits results in
increased lean mass
We first assessed body weight and composition, as well as feeding in animals
consuming a low fat diet for 8 weeks (LF, 10% fat). TH Rictor KO mice weigh
more than control (CTR) mice (Fig. 1A; CTR mice were littermates of TH
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Rictor KO mice that lacked Cre recombinase). The increase in body weight is
due to elevated lean mass as determined by NMR (Fig. 1A). DA neurons in the
hypothalamus have been shown to regulate plasma growth hormone (GH)
concentration [17]. The increase in lean mass, therefore, could stem from
elevated GH levels. There were no differences in GH between genotypes
(data not shown). Importantly, cumulative food intake was not different for TH
Rictor KO mice relative to CTR animals (Fig. 1B) while on the LF diet. Feed
efficiency, the change in total body weight, fat, or lean mass divided by the
cumulative calories consumed over a period of time was not different (Fig. 1C).
These data strongly suggest that TH Rictor KO mice with disrupted mTORC2
signaling within catecholaminergic neurons have intact homeostatic energy
regulation. However, since catecholamines are implicated in salience and
reward, we next determined the role of mTORC2 signaling on the intake of a
high fat (HF, 60% fat), palatable diet.
3.2. Conditional deletion of Rictorin catecholaminergic neurons
results in escalating hyperphagia on high fat (HF) diet
The mesolimbic system is an essential component of the circuitry that evaluates
saliency of natural rewards, including food [18] [19] [20] [21].
Catecholaminergic neurons are an essential component of this system. Given
their role in food reward, we hypothesized that mTORC2 signaling in TH
expressing neurons might play a pivotal role in regulating food consumption in
animals exposed to palatable high fat diet (HF, 60% fat). Unlike on LF diet, TH
Rictor KO mice consume significantly more calories than CTR animals on HF
diet (Fig. 2A, [11_TD$DIFF]inset). When excess HF diet intake is visualized cumulatively by
[(Fig._1)TD$FIG]
Fig. 1. Energy balance and body composition of TH Rictor KO mice on low-fat diet (LF).
(A) Body composition of TH Rictor KO and CTR mice; n = 8 per genotype. (B) Cumulative food
intake (LF diet) was measured over the course of eight weeks and was found to be
indistinguishable from the LF food intake of CTR animals; n = 6–7 per genotype. (C) Feed
efficiency over the corresponding eight week period was calculated as change in total body
weight, fat, or lean mass in grams divided by total kcal consumed. Values represent mean ± SEM;
***p < 0.001.
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subtracting average LF diet consumption from daily HF diet consumption,
continuously escalating HF diet consumption is observed only in TH Rictor
KO mice (Fig. 2A). This was calculated by subtracting the average caloric
consumption on a low fat diet from the caloric consumption on the high fat
diet of the correspondent genotype each day. Thus, CTR animals modulate
their high-fat food intake, while TH Rictor animals continuously increase
consumption of the high-fat diet over time (Fig. 2A). Concomitantly, TH
Rictor KO mice show a rapid increase in body weight and lean mass after
only six days on a high fat diet (Fig. 2B) without changes in feed efficiency
(Fig. 2C).
[(Fig._2)TD$FIG]
Fig. 2. Energy balance of TH Rictor KO mice on high-fat diet (HF). (A) Genotype-specific
difference in cumulative consumption of HF food relative to LF food consumption (average
low-fat food intake was subtracted from high-fat food intake in kcal); n = 7–9 per treatment
per genotype. Inset: Cumulative food intake (high-fat diet) was measured over the course of
eight weeks. In both graphs, high-fat food-induced escalating hyperphagia is shown for TH
Rictor KO mice compared to CTR animals; n = 6–7 per genotype. (B) Body composition over
the corresponding eight week period was measured and graphed to compare with CTR mice;
n = 8 per genotype. (C) Feed efficiency over the corresponding eight week period was
calculated as change in total body weight, fat, or lean mass in grams divided by total kcal
consumed); n = 4–5 per genotype. Values represent mean ± SEM; ***p < 0.001, **p < 0.01,
*p < 0.05.
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3.3. Conditional deletion of Rictor in TH expressing neurons
results in impaired DA neurotransmission and aberrant
DA-dependent behaviors
The catecholaminergic system modulates motivated behaviors such as feeding,
drinking, and locomotion as well as reward. TH Rictor KO mice exhibit normal
food intake when exposed to a LF diet. However, they display exaggerated
hyperphagiatoa HF diet. This hyperphagia could stem from disrupted DA
neurotransmission in midbrain. To explore this possibility, we first analyzed
DA tissue content in the ventral striatum. TH Rictor KO mice have reduced DA
tissue content in the Nucleus Accumbens (NAc) relative to CTR animals
(Fig. 3A), suggesting impaired mesolimbic DA tone in the conditional KO mice.
Importantly, DA metabolites DOPAC, 3-MT, and HVA were not significantly
changed in the TH Rictor KO mice (data not shown), suggesting altered DA
homeostasis. This observation warrants further exploration.
Analysis of locomotor activity is an efficient method to evaluate the integrity of
the DA neurotransmission in rodents. Novelty-induced hyperactivity is modulated
by the mesolimbic DA pathway [22]. TH Rictor KO mice display exaggerated
hyper locomotion in a novel environment relative to CTR animals (Fig. 3B).
Importantly, rodents that are prone to elevated novelty-induced hyperactivity, also
exhibit heightened sensitivity to psycho stimulants, such as amphetamine (AMPH)
[9] [10] [23]. Therefore, we challenged habituated (see Methods) TH Rictor KO
mice with a single dose of AMPH. TH Rictor KO animals show increased
AMPH-induced hyperactivity compared to their wild type counterparts (Fig. 3C).
[(Fig._3)TD$FIG]
Fig. 3. Aberrant NAc DA tone and disrupted DA-dependent behaviors in TH Rictor KO mice.
(A) DA tissue content as measured by HPLC in NAc homogenates; n = 6–8 per genotype.
(B) Novelty-induced locomotion: horizontal movement measured in open field chambers in 5-min
intervals; n = 8 per genotype. Data are represented as area under the curve (AUC) for the first
30 min in the chamber. (C) AMPH-induced locomotion; n = 7–8 per treatment per genotype. CTR
and TH Rictor KO mice were habituated to saline injections and open field chambers for six days.
On day seven AMPH (2 mg/kg) was administered i.p. and horizontal locomotor activity recorded in
5-min intervals. Data are represented as area under the curve (AUC) from time of injection to
30 min, [2_TD$DIFF] expressed as percent of corresponding saline control. Values represent mean ± SEM;
**p < 0.01, *p < 0.05.
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These data support the notion that genetic deletion of Rictor in the TH expressing
cells results in altered mesolimbic DA tone associated with exaggerated high fat
hyperphagia and AMPH-induced hyperlocomotion.
4. Discussion
Regulation of energy balance is intricately regulated by the central nervous
system. Food intake is controlled by both homeostatic and hedonic circuits,
which rely not only on objective physiological cues supported by peripheral
systems, but also on subjective experiences such as memory, motivation, and
pleasure, all supported by environmental cues [12] [18] [21] [24] [25]. One of
the key regulators of energy balance, the adiposity negative feedback hormone
insulin, signals via mTORC2/Akt pathway in the brain, and modulates both
homeostatic and hedonic neural circuits [8] [12] [26]. Proper integration of
homeostatic signals with those “sensing” the saliency of food is necessary for
appropriate energy balance regulation. Aberrant brain insulin signaling causes
abnormal feeding behaviors, including hyperphagia [11] and has been shown to
regulate catecholaminergic neurotransmission through Akt [10] [16].
Dopamine is essential in modulation of many vital behaviors including
movement, cognition, motivation, and salience. Motivation to obtain natural
rewards such as food is vital for the organismal survival, and was shown to
depend on central DA neurotransmission. Indeed, motivation for seeking food
as well as the reward and satiety we feel when we eat have been extensively
studied in humans using imaging techniques [27] [28]. Mere consumption of
food is a motivated behavior that is controlled by the DA signaling [29].
Our laboratory and others have previously shown that aberrant signaling through
the Akt pathway which is stimulated by insulin and other neuropeptides,
disrupts central DA neurotransmission [30] [31] [32] [33]. These data include
in vivo studies demonstrating that aberrant peripheral insulin signaling caused by
either high-fat diet or pharmacological interventions leads to altered central DA
signaling [11] [34]. Therefore, in this study we sought to determine if disrupted
mTORC2/rictor/Akt signaling specifically in TH expressing neurons, which
include DA cells, leads to abnormal feeding and altered metabolism.
5. Conclusion
Here, we demonstrate that mTORC2 signaling in catecholaminergic neurons
modulates brain DA homeostasis, and is implicated in DA-related behaviors
such as novelty-induced hyperlocomotion, hypersensitivity to the
psychostimulant AMPH, and, importantly, HF diet-specific hyperphagia.
Importantly, studies in metabolic chambers did not reveal any differences in
basal activity or locomotion between genotypes, suggesting that the increased
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high-fat food intakewas not caused by increased locomotor activity of the TH
Rictor mice. Our data support a model in which disrupted mTORC2 signaling
within catecholaminergic neurons creates aberrant striatal DA neurotransmission,
and causes HF diet-specific exaggerated hyperphagia. These data suggest that
mTORC2 signaling defects localized to the catecholaminergic pathways are capable
of overriding homeostatic circuits, and drives aberrant DA-dependent behaviors.
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